News

BioVie Inc. Plans Exciting New Public Stock Offering

BioVie Inc. Plans Exciting New Public Stock Offering

BioVie Inc. Plans Public Offering for Common Stock

BioVie Inc. (NASDAQ: BIVI) is a clinical-stage company focused on developing innovative drug therapies for advanced liver diseases and neurological disorders. Recently, the company announced its plan to sell shares of common stock and pre-funded warrants through a public offering. This move aims to generate funds for operational purposes while also supporting its ongoing research and development efforts.

Details of the Offering

The public offering will consist of shares of common stock along with warrants, which will be available under specific conditions influenced by market trends. It's important to note that the final terms and execution of the offering will depend on the current market environment.

Role of Placement Agent

ThinkEquity is acting as the sole placement agent in this offering, facilitating the process to help ensure everything goes smoothly.

Intended Use of Proceeds

BioVie plans to use the net proceeds from this upcoming offering primarily for working capital and various corporate needs. This funding is essential for the company to continue its vital research aimed at addressing significant medical challenges.

Regulatory Framework

The securities sale will comply with a shelf registration statement filed under Form S-3, which has been approved by the U.S. Securities and Exchange Commission (SEC). To promote transparency, the company is making all relevant documentation accessible to stakeholders, providing comprehensive details about the offering.

About BioVie Inc.

BioVie Inc. is committed to researching and developing cutting-edge drug therapies for serious medical conditions, including advanced liver diseases and neurodegenerative disorders. One of its notable products, NE3107, proactively addresses neuroinflammation linked to conditions like Alzheimer's and Parkinson's diseases. Clinical trials have shown promising results, indicating that NE3107 may help enhance cognitive functions in patients.

Clinical Trials and Innovations

Exciting data from trial studies suggest that BioVie’s work could lead to meaningful advancements in patient care. Findings from major conferences highlight the effectiveness of NE3107, while several ongoing Phase 2 trials are set to further validate its clinical benefits. Additionally, the company is also developing BIV201, which targets ascites caused by liver cirrhosis and has received the FDA's Fast Track designation.

Investor Relations and Contact Information

If you're interested in learning more about this public offering or about BioVie itself, you can reach out to Bruce Mackle, Managing Director at LifeSci Advisors. He is available to provide assistance through official investor relations channels, ensuring that any questions you have are addressed promptly.

Conclusion

As BioVie Inc. proceeds with its public offering, it marks an exciting phase for the company, underlining its dedication to innovation in the pharmaceutical field. All stakeholders and investors are encouraged to stay updated and consider the potential implications of this new opportunity as the company advances.

Frequently Asked Questions

What is the main purpose of BioVie Inc.'s public offering?

The offering aims to generate capital for operational expenses and to support ongoing research initiatives.

Who is assisting BioVie with the offering?

ThinkEquity is serving as the sole placement agent for this public offering.

What are the key products being developed by BioVie?

BioVie is focused on developing NE3107 for neurodegenerative diseases and BIV201 for the treatment of liver cirrhosis.

What regulatory approvals does BioVie have?

The company has a shelf registration statement approved by the SEC for this offering.

How can I contact BioVie for more information?

For inquiries, you can reach out to Bruce Mackle at LifeSci Advisors for investor relations.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

PetSmart Charities Adds Strategy Role for Pet Families

Updated Category News Views 51

A pet bowl can become a crisis marker faster than people admit. Housing trouble, empty cupboards, a hurricane, or an unaffordable veterinary bill can turn a loved animal into one more impossible responsibility. That is the uncomfortable reality behind PetSmart Charities' decision to create a vice president of strategic programs and partnerships role and appoint Heather...

Continue Reading
Clickstop's Urbana Expansion Bets on Durable Demand

Updated Category News Views 29

A patch of turned Iowa dirt can say plenty about a company’s nerve. Clickstop broke ground in Urbana on Nov. 19, 2026, for a 43,000-square-foot building, and the message is pretty plain: management believes its recent growth has legs. For a privately held, employee-owned operator serving trucking, construction, lifting and rigging, that is not a casual decision....

Continue Reading
Fervo’s 46% Slide Puts Geothermal Claims Under Fire

Updated Category News Views 105

A 46% haircut from an IPO price has a way of stripping the paint off a growth story. Fervo Energy closed at $14.33 after the October 6 report cited in Hagens Berman’s announcement, well below its $27 IPO price from last May. That does not prove the report is right. It does mean NASDAQ:FRVO investors are staring at questions that go straight to the economic spine of...

Continue Reading
L’Oréal’s Women of Worth Shows Why Brand Patience Matters

Updated Category News Views 12

Twenty-one years is a long time to keep a corporate promise from turning into wallpaper. L’Oréal Paris gathered its 2026 Women of Worth class at the Ebell in Los Angeles on November 18, recognizing 10 nonprofit leaders working on problems that do not yield to a glitzy evening or a tidy slogan. That distinction matters. Cancer survivorship, trafficking prevention,...

Continue Reading
Zesty Takes Kubernetes Cost Control Into GPU Territory

Updated Category News Views 73

GPU waste has become the sort of cloud bill nobody wants to explain upstairs. A company buys scarce, expensive accelerators for AI work, then discovers that real workloads do not politely consume resources in neat, permanent blocks. Demand jumps, memory needs shift, and somebody either over-allocates to avoid trouble or under-allocates and gets ugly out-of-memory...

Continue Reading
Greenberg Traurig Builds Real Estate Bench Further

Updated Category News Views 32

Two real estate lawyers rarely move a market, but they can tell you where the legal work is getting sticky. Greenberg Traurig’s November 19 addition of Steven A. Fein and Kelsey Thayer is not some grand macroeconomic pronouncement, and nobody should pretend otherwise. It is, however, a pretty sensible read on the messy corners of commercial property finance: joint...

Continue Reading
Decibel's Export Engine Masks a Domestic Sales Slip

Updated Category News Views 87

Decibel’s overseas business is doing the heavy lifting, and it is not doing it quietly. Third-quarter net revenue reached $35.1 million, up 7% from a year earlier, while international sales jumped 44% to a record $12.1 million. That split matters more than the headline. Canadian adult-use sales fell 6% to $23.0 million, which means the company is proving it can find...

Continue Reading
V2’s FOAS Bets on Candid Ad Sales Operator Dialogue

Updated Category News Views 121

Ad sales rarely gets fixed by another ballroom panel, and V2 seems to know it. Its new Future of Ad Sales, or FOAS, forum is built around a simpler premise: put senior operators in a small room, keep vendors and conference theatrics out of the way, and let people compare the ugly real-world details of running revenue machines. Announced November 19, 2026, FOAS is an...

Continue Reading
OFRM Recall Leaves Investors Facing Hard Questions

Updated Category News Views 60

Nothing wrecks a young consumer brand’s glow faster than a recall involving toddlers, and Once Upon A Farm has just learned that lesson in the ugliest possible way. On November 2, 2026, shares of NYSE:OFRM fell 37% to close at $9.44. That left the stock roughly 47% below its $18 IPO price. Those are not the garden-variety bruises of a weak quarter. That is the market...

Continue Reading
Mudrick Urges Doncasters to Test a Strategic Sale Now

Updated Category News Views 62

Castings are rarely glamorous until nobody can get them, and Mudrick Capital is betting that ugly little industrial reality could make Doncasters worth far more in a takeover than the market currently credits. The event-driven investor, which says it owns roughly 4.3% of DPC Holdings Limited, has asked the board to quietly evaluate strategic alternatives, including a sale...

Continue Reading

Top 5 Most Recently Viewed Articles

Ryan Debenham Steps Up as New CEO of GRIN to Drive Growth

Updated Category News Views 312

Ryan Debenham Takes Leadership Role at GRIN GRIN, a leading creator management platform, has announced an exciting transition in leadership with Ryan Debenham becoming the new CEO. Previously serving as the company's president, Debenham's promotion marks a significant step for GRIN as it aims to enhance its offerings and deepen its engagement with brand partnerships....

Continue Reading
Impetus Wellness Group Launches Innovative VMS Platform

Updated Category News Views 282

Impetus Wellness Group Launches Innovative VMS Platform Impetus Wellness Group has just announced an exciting new venture enabled by a strategic partnership with Reliance Vitamin. This collaboration is set to elevate the wellness industry, especially in the realm of vitamins, minerals, and supplements (VMS). Leadership Structure and Vision At the helm of Impetus is a...

Continue Reading
MEXC Ventures Collaborates with Solana ANZ for Web3 Event

Updated Category News Views 211

MEXC Ventures and Solana ANZ: A New Era for Web3 Events MEXC Ventures has made a significant entry into the Web3 ecosystem by partnering with Solana ANZ to host the Web3 Builders and Traders Night. This collaboration takes place in a vibrant locale, signifying MEXC Ventures' commitment to the growth of the blockchain community. A Successful Gathering of Web3 Professionals...

Continue Reading
Investors Take Action: Join the Sable Offshore Securities Case

Updated Category News Views 212

Investors Have a Unique Opportunity in Sable Offshore Case Many investors have encountered challenges in the stock market, particularly with the case involving Sable Offshore Corp. (NYSE: SOC). The situation has prompted a significant response from the legal community, aiming to support those impacted. Faruqi & Faruqi, LLP, a renowned national securities law firm, is...

Continue Reading
Kaplan Achieves Double Recognition in Education Equity Awards

Updated Category News Views 193

Kaplan's Remarkable Achievement in Educational Equity Recently, Kaplan has been honored as a double winner in the prestigious American Consortium for Equity in Education's 2024 Excellence in Equity – Industry Impact Awards. This recognition is significant, highlighting Kaplan's outstanding contributions in two important categories: Company of the Year - Higher Education...

Continue Reading